TY - JOUR
T1 - Erratum to
T2 - Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 9, (1588-1601), 10.1007/s00259-017-3728-y)
AU - Bozkurt, Murat Fani
AU - Virgolini, Irene
AU - Balogova, Sona
AU - Beheshti, Mohsen
AU - Rubello, Domenico
AU - Decristoforo, Clemens
AU - Ambrosini, Valentina
AU - Kjaer, Andreas
AU - Delgado-Bolton, Roberto
AU - Kunikowska, Jolanta
AU - Oyen, Wim J.G.
AU - Chiti, Arturo
AU - Giammarile, Francesco
AU - Sundin, Anders
AU - Fanti, Stefano
N1 - Publisher Copyright:
© 2017, Springer-Verlag GmbH Germany.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Unfortunately, due to some indeliberate and inadvertent reasons, Professor Anders Sundin’s name was not included among the authors’ list even though he contributed to the article with all the great efforts and valuable expertise on the field, which all of the authors of this article absolutely agree with and approve that his name should have been among the authors for this article.Professor Sundin contributed to the article with a meticulous review and made valuable additions to the manuscript. Since Professor Sundin is a practising radiologist, his contribution to this guideline was mainly focused on a radiological perspective of PET/CT imaging of neuroendocrine neoplasms and upon his suggestion, some key points from a radiological point of view was added to the manuscript. Professor Sundin’s scientific contribution to this guideline was really very important and had a great impact given the fact that neuroendocrine tumors are aheterogenous group of neoplasms for which an utmost multidisciplinary approach is definitely warranted. Professor Sundin not only contributed to the article in a scientific way and from a radiologist’s perspective but he also had a great contribution by means of English-language editing, due to his personal interest in the English language. All of the authors specifically confirm that Professor Sundin was substantially involved in all of the steps during this work. Professor Sundin made substantial contributions to the conception and design of the work; to the acquisition, analysis, and interpretation of data for the work; and to drafting the work and revising it critically for important intellectual content. Therefore, upon his important contribution to this guideline with his great efforts and distinctive expertise in the field, and on behalf of all of the authors and with their approvals, I hereby state that Professor Sundin’s name should have been among the authors for this article.
AB - Unfortunately, due to some indeliberate and inadvertent reasons, Professor Anders Sundin’s name was not included among the authors’ list even though he contributed to the article with all the great efforts and valuable expertise on the field, which all of the authors of this article absolutely agree with and approve that his name should have been among the authors for this article.Professor Sundin contributed to the article with a meticulous review and made valuable additions to the manuscript. Since Professor Sundin is a practising radiologist, his contribution to this guideline was mainly focused on a radiological perspective of PET/CT imaging of neuroendocrine neoplasms and upon his suggestion, some key points from a radiological point of view was added to the manuscript. Professor Sundin’s scientific contribution to this guideline was really very important and had a great impact given the fact that neuroendocrine tumors are aheterogenous group of neoplasms for which an utmost multidisciplinary approach is definitely warranted. Professor Sundin not only contributed to the article in a scientific way and from a radiologist’s perspective but he also had a great contribution by means of English-language editing, due to his personal interest in the English language. All of the authors specifically confirm that Professor Sundin was substantially involved in all of the steps during this work. Professor Sundin made substantial contributions to the conception and design of the work; to the acquisition, analysis, and interpretation of data for the work; and to drafting the work and revising it critically for important intellectual content. Therefore, upon his important contribution to this guideline with his great efforts and distinctive expertise in the field, and on behalf of all of the authors and with their approvals, I hereby state that Professor Sundin’s name should have been among the authors for this article.
UR - http://www.scopus.com/inward/record.url?scp=85028599610&partnerID=8YFLogxK
U2 - 10.1007/s00259-017-3807-0
DO - 10.1007/s00259-017-3807-0
M3 - Comment/debate
C2 - 28856372
AN - SCOPUS:85028599610
VL - 44
SP - 2150
EP - 2151
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
SN - 1619-7070
IS - 12
ER -